MarketPulse

once-weekly injection

2 articles
BenzingaBenzinga··Vandana Singh

Novo Nordisk Scores Historic FDA Win With First Weekly Basal Insulin

Novo Nordisk wins FDA approval for Awiqli, the first once-weekly basal insulin for Type 2 diabetes, potentially improving patient adherence and capturing significant market share.
NVOFDA approvalclinical trial
GlobeNewswire Inc.GlobeNewswire Inc.··Ascendis Pharma A/S

Ascendis Pharma Wins FDA Clearance for First Weekly Achondroplasia Treatment in Children

Ascendis Pharma wins FDA approval for YUVIWEL, the first once-weekly treatment for pediatric achondroplasia. The therapy offers improved dosing convenience over existing options.
ASNDFDA approvalaccelerated approval